Literature DB >> 25845771

Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation.

Silvia Belotti1, Alessandra Rossi1, Paolo Colombo1, Ruggero Bettini1, Dimitrios Rekkas2, Stavros Politis2, Gaia Colombo3, Anna Giulia Balducci4, Francesca Buttini5.   

Abstract

A Central Composite Design (CCD) was applied in order to identify positive combinations of the production parameters of amikacin sulphate spray-dried powders for inhalation, with the intent to expand the experimental space defined in a previous half-fractional factorial design. Three factors, namely drying temperature, feed rate and ethanol proportion, have been selected out of the initial five. In addition, the levels of these factors were increased from two to three and their effect on amikacin respirability was evaluated. In particular, focus was given on the role of ethanol presence on the formation of the microparticles for inhalation. The overall outcome of the CCD was that amikacin respirability was not substantially improved, as the optimum region coincided with areas already explored with the fractional factorial design. However, expanding the design space towards smaller ethanol levels, including its complete absence, revealed the crucial role of this solvent on the morphology of the produced particles. Peclet number and drug solubility in the spraying solution helped to understand the formation mechanism of these amikacin sulphate spray-dried particles.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amikacin sulphate; Amikacin sulphate (PubChem CID: 45357036); Cystic fibrosis; Dry powder inhaler; Microparticles; Peclet number

Mesh:

Substances:

Year:  2015        PMID: 25845771     DOI: 10.1016/j.ejpb.2015.03.023

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  9 in total

1.  Development and physicochemical characterization of acetalated dextran aerosol particle systems for deep lung delivery.

Authors:  Zimeng Wang; Sweta K Gupta; Samantha A Meenach
Journal:  Int J Pharm       Date:  2017-04-24       Impact factor: 5.875

2.  Computational Fluid Dynamics (CFD) Guided Spray Drying Recommendations for Improved Aerosol Performance of a Small-Particle Antibiotic Formulation.

Authors:  Worth Longest; Amr Hassan; Dale Farkas; Michael Hindle
Journal:  Pharm Res       Date:  2022-02-11       Impact factor: 4.200

3.  Development of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying: In Vitro Characterization and Pharmacokinetic Profiling.

Authors:  Yoshiki Seto; Gen Suzuki; Sharon Shui Yee Leung; Hak-Kim Chan; Satomi Onoue
Journal:  Pharm Res       Date:  2016-03-14       Impact factor: 4.200

4.  Computational Fluid Dynamics (CFD) Simulations of Spray Drying: Linking Drying Parameters with Experimental Aerosolization Performance.

Authors:  P Worth Longest; Dale Farkas; Amr Hassan; Michael Hindle
Journal:  Pharm Res       Date:  2020-05-21       Impact factor: 4.200

5.  Particle Engineering by Nano Spray Drying: Optimization of Process Parameters with Hydroethanolic versus Aqueous Solutions.

Authors:  Khaled Almansour; Raisuddin Ali; Fawaz Alheibshy; Tariq J Almutairi; Rakan F Alshammari; Nasser Alhajj; Cordin Arpagaus; Mustafa M A Elsayed
Journal:  Pharmaceutics       Date:  2022-04-06       Impact factor: 6.525

6.  Inhalable Spray-Dried Chondroitin Sulphate Microparticles: Effect of Different Solvents on Particle Properties and Drug Activity.

Authors:  Susana Rodrigues; Ana M Rosa da Costa; Noelia Flórez-Fernández; María Dolores Torres; Maria Leonor Faleiro; Francesca Buttini; Ana Grenha
Journal:  Polymers (Basel)       Date:  2020-02-12       Impact factor: 4.329

7.  Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler.

Authors:  Francesca Buttini; Irene Pasquali; Gaetano Brambilla; Diego Copelli; Massimiliano Dagli Alberi; Anna Giulia Balducci; Ruggero Bettini; Viviana Sisti
Journal:  Pharm Res       Date:  2015-11-16       Impact factor: 4.200

8.  In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates.

Authors:  Alessandro Giuliani; Anna Giulia Balducci; Elisa Zironi; Gaia Colombo; Fabrizio Bortolotti; Luca Lorenzini; Viola Galligioni; Giampiero Pagliuca; Alessandra Scagliarini; Laura Calzà; Fabio Sonvico
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

9.  Inhalable, Spray-Dried Terbinafine Microparticles for Management of Pulmonary Fungal Infections: Optimization of the Excipient Composition and Selection of an Inhalation Device.

Authors:  Khaled Almansour; Iman M Alfagih; Alhassan H Aodah; Fawaz Alheibshy; Raisuddin Ali; Turki Al Hagbani; Mustafa M A Elsayed
Journal:  Pharmaceutics       Date:  2021-12-30       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.